| 產品名稱 |
Mumps rubulavirus |
| 商品貨號 |
B212135 |
| Classification |
Paramyxoviridae, Rubulavirus |
| Deposited As |
Mumps |
| Agent |
Mumps rubulavirus |
| Strain |
Jones |
| Common Name |
Mumps virus |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Throat washing one day after onset of parotitis |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
Titrations most accurate using hemadsorption technique. The Jones strain was passaged extensively in CE and CE TC to attenuate it for man. This preparation has tested positive for Mycoplasma contamination. Titrations most accurate using hemadsorption technique. |
| Effect on Host |
Yes, in vitro effects: Cytopathic effects with low dilutions of virus CPE with low dilutions of virus |
| Recommended Host |
chicken embryo fibroblasts Host of Choice: Chick embryo fibroblasts chicken embryo fibroblasts; human kidney cells; marmoset kidney cells; rhesus monkey kidney cells; HEp-2 cells (ATCC CCL-23) |
| Growth Conditions |
Duration: 5-7 days |
| Name of Depositor |
F Deinhardt, G Shramek |
| Source |
Throat washing one day after onset of parotitis |
| References |
Shramek G, Deinhardt F. Development of an attenuated mumps virus vaccine. II. Immune response of animals to vaccination with inactivated and live attenuated mumps viruses. J. Immunol. 102: 1093-1098, 1969. PubMed: 5768187
|
